MGRX

Insider Trades

Name	Value	Action	Price	Current Price
Hamilton Alex P.Director $35k108.4k shares SellJun 26, 2024 $0.32 --
Hamilton Alex P.Director $5.1k16.6k shares SellJun 25, 2024 $0.31 --
Hamilton Alex P.Director $153k125k shares SellNov 19, 2025 $1.22 --
Johnston Eugene MCFO $11k10k shares SellDec 5, 2025 $1.13 --
Johnston Eugene MCFO $6.0k5k shares SellDec 9, 2025 $1.20 --
Johnston Eugene MCFO $3.9k3.3k shares SellDec 15, 2025 $1.17 --

News

defenseworld.netMangoceuticals (NASDAQ:MGRX) versus Lipocine (NASDAQ:LPCN) Financial Contrastdefenseworld.netApr 26

defenseworld.netHead to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX)defenseworld.netApr 6

benzinga.comMangoceuticals Stock Doubles After Texas Lawsuitbenzinga.comMar 23

Trade MGRX

About Mangoceuticals, Inc.

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

CEO: Jacob D. Cohen
IPO Date: Mar 21, 2023

Market Data

Open: $0.3327
High: $0.3327
Low: $0.3061
Volume: 424.4K
Avg Volume: 5.9M
52W High: $2.75
52W Low: $0.162

Valuation

Market Cap: $3.2M
Enterprise Value: $3.3M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-5.9M
Revenue: $456k
Net Income: $-21M
Cash: $1.5M
Debt: $308k

Events

EarningsMay 19

actual -0.22